Concepedia

Susan L. Kelley

SL

20

Publications

2.5K

Citations

18

H-Index

1982

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Dana-Farber Cancer Institute

University of Michigan

Multiple Myeloma Research Foundation

University of Chicago

Susan L. Kelley is an author at Bristol-Myers Squibb (United States) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1982–2012

20

Publications

20

Overexpression of Metallothionein Confers Resistance to Anticancer Drugs

Susan L. Kelley, Alakananda Basu, Beverly A. Teicher et al. · Science · 1988 · 604 citations

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

Judith R. Abrams, Mark Lebwohl, Cynthia Guzzo et al. · Journal of Clinical Investigation · 1999 · 598 citations · Full text

Blockade of T Lymphocyte Costimulation with Cytotoxic T Lymphocyte–Associated Antigen 4–Immunoglobulin (Ctla4ig) Reverses the Cellular Pathology of Psoriatic Plaques, Including the Activation of Keratinocytes, Dendritic Cells, and Endothelial Cells

Judith R. Abrams, Susan L. Kelley, Elizabeth Hayes et al. · The Journal of Experimental Medicine · 2000 · 319 citations · Full text

, , +22

Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib

Paul G. Richardson, David S. Siegel, Rachid Baz et al. · Blood · 2012 · 161 citations · Full text

Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin

Paul F. Gores, John S. Najarian, E. Stephanian et al. · The Lancet · 1993 · 161 citations

, , +8

Rows per page

1–5 of 20